Notice of Intent to Sole Source Life Technologies Corporation

Special NoticeActive

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in BETHESDA, MD
  • Industry: In-Vitro Diagnostic Substance Manufacturing

Contract Details

Notice ID
NOI-CC-25-008722
Opportunity Type
Special Notice
Sub-Agency
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH - CC
Posted Date
Wednesday, August 27, 2025
Response Deadline
Not specified
PSC Code
6550
Set-Aside
Full & Open Competition
Place of Performance
BETHESDA, MD, 20892
Status
Active

Description

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for AIM V MED CTS 1000ml, DYNABEADS CD3/CD28 CTS 10 ML, HEPES and RPMI 1640 100ML Center for Cellular Engineering (CCE) uses AIM V MED CTS 1000ml, DYNABEADS CD3/CD28 CTS 10 ML, HEPES and RPMI 1640 100ML, material and reagents for patient care responsibilities and these materials are used to manufacture cell-based therapies for patients. All materials have been validated in manufacturing processes to ensure they are of the appropriate quality and that they produce the desired results. In addition, all materials are approved by the Center for Cellular Engineering Quality Assurance Department. Although the material and reagents are ava

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for in-vitro diagnostic substance manufacturing in BETHESDA, MD.